EEE Online Module banner
EEE ONLINE MODULES
INSPIRE – Updates in Lung Cancer●
FEATURED VIDEOS
Care for the Skin: EGFR TKI-related Dermatological Adverse Events
Watch A/Prof. Lee take us through the timeline of dermatological AEs associated with EGFR-TKIs as well as the pathophysiological mechanisms underpinning them. Learn how to distinguish between the various cutaneous AEs and the evidence-based treatments for them.
Speaker: Assoc Prof Lee Haur Yueh Document ID: PC-MY-101366
Learn More
Care for the Skin: EGFR TKI-related Dermatological Adverse Events
 
MORE videos
Evidence for Sequential Therapy in EGFR M+ NSCLC
 

Evidence for Sequential Therapy in EGFR M+ NSCLC

Speaker: Dr. Yap Beng Khiong

Effectiveness of Dose Modification Strategies with Afatinib: A Real-World Experience
 

Effectiveness of Dose Modification Strategies with Afatinib: A Real-World Experience

Speaker: Assoc Prof Dr Ho Gwo-Fuang

Strategies in Managing EGFR M+ NSCLC
 

Strategies in Managing EGFR M+ NSCLC

Speaker: Dr. Lim Chun Sen

 
Tumour Heterogeneity in Lung Cancer - Asian setting
 

Tumour Heterogeneity in Lung Cancer - Asian setting

Speaker: A/Prof. Daniel Tan

 
Treatment stratergy with EGFR-TKIs - Asian setting
 

Treatment stratergy with EGFR-TKIs - Asian setting

Speaker: Prof. Tony Mok

 
Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Q&A session)
 

Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Q&A session)

Speaker: Dr. Maximilian Hochmair

 
Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Presentation)
 

Running the Marathon: Updated Evidence on Sequential EGFR TKI Approach in NSCLC (Presentation)

Dr. Maximilian Hochmair

 
PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)
 

PeRsonalized apprOach in Lung adenocarciNoma with EGFR-TKI therapy (PROLONG)

Assoc Prof Dr Ho Gwo-Fuang

 
Uncovering the Uncommon: Efficacy of Afatinib in Uncommon and Compound Mutations
 

Uncovering the Uncommon: Efficacy of Afatinib in Uncommon and Compound Mutations

Dr Cheah Soon Keat

 
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)
 

Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Lecture)

Speaker: Prof. Jin-Hyoung Kang

 
Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Q&A)
 

Taking Cancer On Webinar – Let’s TOAST to Maximising Time on EGFR-TKI Therapy (Q&A)

Speaker: Prof. Jin-Hyoung Kang